IM Cannabis Corp. (IMCC)
| Market Cap | 2.19M -78.6% |
| Revenue (ttm) | 32.25M -12.6% |
| Net Income | -12.62M |
| EPS | -57.94 |
| Shares Out | 1.65M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 46,774 |
| Open | 1.310 |
| Previous Close | 1.350 |
| Day's Range | 1.250 - 1.380 |
| 52-Week Range | 1.200 - 77.100 |
| Beta | 2.21 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 12, 2026 |
About IMCC
IM Cannabis Corp. engages in importation, distribution and sale of medical cannabis products in Israel and Germany. It provides medical cannabis dried flowers; and full-spectrum cannabis extracts under the IMC, BLKMT, and LOT420 brands. The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is headquartered in Vancouver, Canada.
Financial Performance
In 2025, IM Cannabis's revenue was 54.73 million, an increase of 1.30% compared to the previous year's 54.03 million. Losses were -11.32 million, 6.93% more than in 2024.
Financial numbers in CAD Financial StatementsNews
IM Cannabis registers to sell 2.8M common shares for holders
This filing relates to the offer and sale from time to time by the selling stockholders of up to 2.8M common shares. The company is not selling any shares under…
IM Cannabis Registration statement: Registration filing
IM Cannabis filed a registration statement on October 8, 2026, providing details about a securities offering with the SEC.
IM Cannabis Announces Closing of the Sale of IMC Holdings and Its European-Focused Operations, Strengthens Balance Sheet
Transaction Expected to Result in an Improvement of Approximately C$3 Million in Shareholders' Equity VANCOUVER, BC and GLIL YAM, Israel, Sept. 29, 2026 /PRNewswire/ -- IM Cannabis Corp. (the "Company...
IM Cannabis Announces Closing of US$1.31 Million Registered Direct Offering of Common Shares
VANCOUVER, BC and GLIL YAM, Israel, Sept. 24, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMCC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, today a...
IM Cannabis regains compliance with Nasdaq minimum bid price requirement
IM Cannabis (IMCC) received written notice from Nasdaq indicating that the company has regained compliance with the minimum bid price requirement which requires listed securities to maintain a minimum...
IM Cannabis Regains Compliance with Nasdaq Minimum Bid Price Requirement
VANCOUVER and GLIL YAM, Israel, Sept. 23, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, today announ...
IM Cannabis prices 655,000 shares at $2.00 in registered direct offering
IM Cannabis (IMCC) announced that it has entered into securities purchase agreements with certain accredited investors for the purchase and sale of 655,000 common shares at a purchase price of…
IM Cannabis Announces Pricing of US$1.31 Million Registered Direct Offering of Common Shares
VANCOUVER, BC and GLIL YAM, Israel, Sept. 23, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMCC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, today a...
IM Cannabis announces LOI to acquire 51% of Space Defense Innovations
IM Cannabis (IMCC) announced that it has entered into a non-binding Letter of Intent, or LOI, to acquire 51% of the issued and outstanding equity securities of Space Defense Innovations,…
IM Cannabis Enters Non-Binding Agreement to Acquire 51% of Space Defense Innovations, Operating in the European Tactical UAS Market
The Company has entered a non-binding Letter of Intent to acquire control of Space Defense Innovations LLC, which is engaged in distributing BlueBird Aero Systems' advanced tactical UAS and unique Hyb...
IM Cannabis Raises US$225,000 of Gross Proceeds in Convertible Note Financing
TORONTO and GLIL YAM, Israel, Sept. 2, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMCC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, today announce...
IM Cannabis Shares Commence Trading on 30:1 Consolidated Basis
TORONTO and GLIL YAM, Israel, Aug. 27, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, announces that,...
IM Cannabis trading halted, news pending
19:50 EDT IM Cannabis (IMCC) trading halted, news pending
IM Cannabis Announces Intention to Complete 30:1 Share Consolidation to Support Nasdaq Minimum Bid Price Compliance
TORONTO and GLIL YAM, Israel, Aug. 18, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, announces that ...
IM Cannabis Enters into Agreement to Sell IMC Holdings and European- Focused Assets
Transaction Expected to Result in an Improvement of Approximately CAD$3 million in Shareholders' Equity TORONTO and GLIL YAM, Israel, Aug. 17, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Com...
IM Cannabis Corp. Announces Second Quarter and First Half 2026 Financial Results
TORONTO and GLIL YAM, Israel, Aug. 13, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), today announced its financial results for the three and six months ended June 30,...
IM Cannabis Earnings release: Q2 2026
IM Cannabis released its Q2 2026 earnings on August 13, 2026, summarizing the period's financial results.
IM Cannabis Raises US$250,000 of Gross Proceeds in Convertible Note Financing
TORONTO and GLIL YAM, Israel, Aug. 7, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, today announced ...
IM Cannabis Provides Corporate Update
TORONTO and GLIL YAM, Israel, July 27, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, announces that ...
IM Cannabis signs LoI to sell European activities
IM Cannabis (IMCC) has entered into a non-binding letter of intent with Slil.com Holding Ltd., a privately-held Israeli entity beneficially owned and controlled by Oren Shuster, the company’s CEO, a…
IM Cannabis Corp. Enters into Letter of Intent to Sell its European Activities, Expects to Significantly Reduce Debt by CAD$10.5 million
Transaction Expected to Streamline Operations, Retain Israeli Business, Improve Working Capital through debt reduction and Cash Flow While Enabling the Pursuit of New Investment Opportunities as Previ...
IM Cannabis Announces Form F-3 Resale Registration Statement Filing
TORONTO and GLIL YAM, Israel, June 9, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, announces that, ...
IM Cannabis registers to sell 17.28M common shares for holders
This filing relates to the offer and sale from time to time by the selling stockholder of up to 17.28M common shares. The company is not selling any shares under…
IM Cannabis Registration statement: Registration filing
IM Cannabis filed a registration statement on June 9, 2026, providing details about a securities offering with the SEC.
IM Cannabis Corp. Announces First Quarter 2026 Financial Results
TORONTO and GLIL YAM, Israel, May 13, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, today announced ...